Efficacy of recombinant Factor VIIa (rFVIIa) when administered in the home to control joint, muscle and mucocutaneous bleeds in hemophiliacs with inhibitors

被引：0
|
作者：
Key, NS [1 ]
机构：
[1] UNIV MINNESOTA, US RFVIIA HOME THERAPY STUDY GRP, MINNEAPOLIS, MN 55455 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：PS206 / PS206
页数：1
相关论文
共 20 条
  • [1] Efficacy of recombinant factor VIIa (rFVIIa) when administered in the home to control joint, muscle and mucocutaneous bleeds in hemophiliacs with inhibitors.
    Key, NS
    [J]. BLOOD, 1997, 90 (10) : 149 - 149
  • [2] Home treatment with recombinant factor VIIa (rFVIIa) in hemophilia A or B patients with inhibitors
    Laurian, Y
    Goudemand, J
    Négrier, C
    Vicariot, M
    Marqués-Verdier, A
    Fonlupt, J
    Gaillard, S
    Fressinaud, E
    Dirat, G
    Sultan, Y
    Faradji, A
    Clayessens, S
    Guérois, C
    Peynet, J
    Bertrand, MA
    Digy, JP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 15 - 15
  • [3] American experience with home use of NovoSeven(R): Recombinant factor VIIa in hemophiliacs with inhibitors
    Shapiro, AD
    [J]. HAEMOSTASIS, 1996, 26 : 143 - 149
  • [4] Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors
    Mauser-Bunschoten, EP
    Koopman, MMW
    Goede-Bolder, ADE
    Leebeek, FWG
    Van der Meer, J
    Kooij, GMV
    Van der Linden, PWG
    [J]. HAEMOPHILIA, 2002, 8 (05) : 649 - 656
  • [5] Safety and Efficacy of Recombinant Factor VIIa ( rFVIIa) in Congenital Hemophilia with Inhibitors (CHwI) in the Home Treatment Setting: Systematic Review of Clinical Studies and Registries
    Young, Guy
    Escobar, Miguel
    Pipe, Steven
    Cooper, David L.
    [J]. BLOOD, 2015, 126 (23)
  • [6] Patient/Caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE)
    Young, G.
    Shapiro, A. D.
    Walsh, C. E.
    Gruppo, R. A.
    Gut, R. Z.
    Cooper, D. L.
    [J]. HAEMOPHILIA, 2012, 18 (03) : 392 - 399
  • [7] RECOMBINANT FACTOR-VIIA FOR TREATMENT OF SERIOUS BLEEDS AND FOR COVER OF SURGICAL-PROCEDURES IN HEMOPHILIACS AND NONHAEMOPHILIACS WITH INHIBITORS TO FACTOR-VIII OR FACTOR-IX
    FELDSTEDT, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 282 - 282
  • [8] Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint
    Saxon, BR
    Shanks, D
    Jory, CB
    Williams, V
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (04) : 1126 - 1127
  • [9] Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial
    De Paula, Erich V.
    Kavakli, Kaan
    Mahlangu, Johnny
    Ayob, Yasmin
    Lentz, Steven R.
    Morfini, Massimo
    Nemes, Laszlo
    Salek, Silva Z.
    Shima, Midori
    Windyga, Jerzy
    Ehrenforth, Silke
    Chuansumrit, Ampaiwan
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (01) : 81 - 89
  • [10] Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: Improved efficacy with higher dosing
    Abshire, TC
    [J]. SEMINARS IN HEMATOLOGY, 2004, 41 (01) : 3 - 7
12